References
Rubin LA, Hawker GA, Peltekova VD, et al.: Determinants of peak bone mass, clinical and genetic analyses in a young female Canadian cohort. J Bone Miner Res 1999, 14:633–643.
Springer JE, Cole DEC, Rubin LA, et al.: Vitamin D receptor genotypes as independent genetic predictors of decreased bone mineral density in primary biliary cirrhosis. Gastroenterology 1999, in press.
Kobayashi S, Inoue S, Hosoi T, et al.: Association of bone mineral density with polymorphism of the estrogen receptor gene.J Bone Miner Res 1996, 11:306–311.
Uitterlinden AG, Burger H, Huang Q, et al: Relation of alleles of the collagen type 1a1 gene to bone density and the risk of osteoporotic fractures in postmenopausal women. N Engl J Med 1998, 338:1016–1021.
Janes CH, Dickson ER, Okazaki R: Role of hyperbilirubinemia in the impairment of osteoblast proliferation associated with cholestatic jaundice.J Clin Invest 1995, 95:2581–2586.
Slatopolsky E: The interaction of parathyroid hormone and aluminum in renal osteodystrophy.Kidney Int 1987, 31:842–854.
Diamond T, Stiel D, Mason R, et al: Serum vitamin D metabolites are not responsible for low turnover osteoporosis in chronic liver disease.J Clin Endocrin Metab 1989, 69:1234–1239.
Matloff DS, Kaplan MM, Neer RM, et al: Osteoporosis in primary biliary cirrhosis: effects of 25-hydroxyvitamin D3 treatment.Gastroenterology 1982, 83:97–102.
Wang YJ, Wu JC, Lee SD, et al.: Gonadal dysfunction and changes in sex hormones in postnecrotic cirrhotic men: a matched study with alcoholic cirrhotic men. Hepatogastroenterology 1991, 38:531–534.
Hodgson SF, Dickson ER, Eastell R, et al.: Rates of cancellous bone remodeling and turnover in osteopenia associated with primary biliary cirrhosis. Bone 1993, 14:819–827.
Hay JE, Lindor KD, Wiesner RH, et al.: The metabolic bone disease of primary sclerosing cholangitis. Hepatology 1991, 14:257–261.
Angulo P, Therneau TM, Jorgensen RA, et al.: Bone disease in patients with primary sclerosing cholangitis: prevalence, severity and prediction of progression. J Hepatol 1998, 29:729–735.
Eastell R, Dickson ER, Hodgson S, et al.: Rates of vertebral bone loss before and after liver transplantation in women with primary biliary cirrhosis. Hepatology 1991, 14:296–300.
Porayko MK, Wiesner RH, Hay JE, et al.: Bone disease in liver transplant recipients: incidence, timing and risk factors Transplant Proc 1991, 23:1462–1465.
Monegal A, Navasa M, Guanabens N, et al.: Osteoporosis and bone mineral metabolism disorders in cirrhotic patients referred for orthotopic liver transplantation. Calcif Tissue Int 1997, 60:148–154.
Bonkovsky HL, Hawkins M, Steinberg K, et al.: Prevalence and prediction of osteopenia in chronic liver disease. Hepatology 1990, 12:273–280.
Crippin JS, Jorgensen RA, Dickson ER, Lindor KD: Hepatic osteodystrophy in primary biliary cirrhosis: effects of medical treatment. Am J Gastroenterol 1994, 89:47–50.
Guanabens N, Pares A, Monegal A, et al.: Etidronate versus fluoride for treatment of osteopenia in primary biliary cirrhosis: preliminary results after 2 years. Gastroenterology 1997, 113:219–224.
Adachi JD, Bensen GB, Brown J, et al.: Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis. N Engl J Med 1997, 337:382–387.
Wolfhagen FHJ, van Buren HR, denOuden JW, et al.: Cyclical etidronate in the prevention of bone loss in corticosteroidtreated primary biliary cirrhosis: a prospective, dcontrolled pilot study. J Hepatol 1997, 26:325–330.
Lindor KD, Jorgensen RA: Etidronate for cholestasis induced osteoporosis: a randomized trial [abstract]. Gastroenterology 1999,116:A1239.
Lindor KD, Janes CH, Crippen JS, et al.: Bone disease in primary biliary cirrhosis: does ursodeoxycholic acid make a difference? Hepatology 1995, 21:389–392.
Floreani A, Chiaramonte M, Giannini S, et al. Longitudinal study on osteodystrophy in primary biliary cirrhosis (PBC) and a pilot study on calcitonin treatment. J Hepatol 1991, 12:217–223.
Dawson-Hughes B, Haris SS, Krall EA, Dallal GE: Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med 1997, 337:670–676.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Heathcote, J. Osteoporosis in chronic liver disease. Curr Gastroenterol Rep 1, 455–458 (1999). https://doi.org/10.1007/s11894-999-0001-y
Issue Date:
DOI: https://doi.org/10.1007/s11894-999-0001-y